(Q38294596)

1 September 2017

Differential effects of heparin saccharides on the formation of specific fibroblast growth factor (FGF) and FGF receptor complexes (English)

1 reference

1 September 2017

1 reference

5

1 reference

1 September 2017

Maryse Delehedde

6

0 references

author name string

Olga Ostrovsky

1

1 reference

1 September 2017

Bluma Berman

2

1 reference

1 September 2017

John Gallagher

3

1 reference

1 September 2017

Barbara Mulloy

4

1 reference

1 September 2017

Dina Ron

7

1 reference

1 September 2017

language of work or name

English

0 references

publication date

19 November 2001

1 reference

Journal of Biological Chemistry

1 September 2017

1 reference

1 September 2017

277

1 reference

1 September 2017

2444-2453

1 reference

1 September 2017

4

1 reference

Increased expression of keratinocyte growth factor in human pancreatic cancer

1 September 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108540200

Determination of ligand-binding specificity by alternative splicing: two distinct growth factor receptors encoded by a single gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108540200

Expression cDNA Cloning of the KGF Receptor by Creation of a Transforming Autocrine Loop

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108540200

Pattern of keratinocyte growth factor and keratinocyte growth factor receptor expression during mouse fetal development suggests a role in mediating morphogenetic mesenchymal-epithelial interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108540200

Regulation of signal transduction and signal diversity by receptor oligomerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108540200

Regulated diversity of heparan sulfate

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108540200

Involvement of heparan sulfate and related molecules in sequestration and growth promoting activity of fibroblast growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108540200

Basic fibroblast growth factor binds its receptors, is internalized, and stimulates DNA synthesis in Balb/c3T3 cells in the absence of heparan sulfate

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108540200

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108540200

Selectively desulfated heparin inhibits fibroblast growth factor-induced mitogenicity and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108540200

Fibroblast growth factor receptor signalling is dictated by specific heparan sulphate saccharides

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108540200

Kinetics of basic fibroblast growth factor binding to its receptor and heparan sulfate proteoglycan: a mechanism for cooperactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108540200

Regulation of growth factor activation by proteoglycans: what is the role of the low affinity receptors?

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108540200

Properly oriented heparin-decasaccharide-induced dimers are the biologically active form of basic fibroblast growth factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108540200

Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108540200

Structure of a heparin-linked biologically active dimer of fibroblast growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108540200

Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108540200

FGF binding and FGF receptor activation by synthetic heparan-derived di- and trisaccharides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108540200

Mutations uncouple human fibroblast growth factor (FGF)-7 biological activity and receptor binding and support broad specificity in the secondary receptor binding site of FGFs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108540200

Monomer complexes of basic fibroblast growth factor and heparan sulfate oligosaccharides are the minimal functional unit for cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108540200

Optical biosensor techniques to analyze protein-polysaccharide interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108540200

Interaction of heparan sulfate from mammary cells with acidic fibroblast growth factor (FGF) and basic FGF. Regulation of the activity of basic FGF by high and low affinity binding sites in heparan sulfate

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108540200

Highly sensitive sequencing of the sulfated domains of heparan sulfate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108540200

Importance of size and sulfation of heparin in release of basic fibroblast growth factor from the vascular endothelium and extracellular matrix.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108540200

Studies on heparin degradation. I. Preparation of ( 35 S) sulphamate derivatives for studies on heparin degrading enzymes of mammalian origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108540200

Regulation by heparan sulfate in fibroblast growth factor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108540200

Identification of glypican as a dual modulator of the biological activity of fibroblast growth factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108540200

Chimeric molecules between keratinocyte growth factor and basic fibroblast growth factor define domains that confer receptor binding specificities

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108540200

Structural requirements in heparin for binding and activation of FGF-1 and FGF-4 are different from that for FGF-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108540200

Structural basis for FGF receptor dimerization and activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108540200

Structural interactions of fibroblast growth factor receptor with its ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108540200

Heparin is essential for a single keratinocyte growth factor molecule to bind and form a complex with two molecules of the extracellular domain of its receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108540200

Preferential self-association of basic fibroblast growth factor is stabilized by heparin during receptor dimerization and activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108540200

Efficiency of signalling through cytokine receptors depends critically on receptor orientation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108540200

An antagonist peptide-EPO receptor complex suggests that receptor dimerization is not sufficient for activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108540200

Identification of residues important both for primary receptor binding and specificity in fibroblast growth factor-7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108540200

Heparan Sulfate Proteoglycan Modulates Keratinocyte Growth Factor Signaling through Interaction with both Ligand and Receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108540200

21 January 2018

Identifiers

DOI

10.1074/JBC.M108540200

1 reference

1 September 2017

1 reference